| Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label … D Yannopoulos, J Bartos, G Raveendran, E Walser, J Connett, TA Murray, ... The lancet 396 (10265), 1807-1816, 2020 | 641 | 2020 |
| Long interdialytic interval and mortality among patients receiving hemodialysis RN Foley, DT Gilbertson, T Murray, AJ Collins New England Journal of Medicine 365 (12), 1099-1107, 2011 | 500 | 2011 |
| A neutralizing monoclonal antibody for hospitalized patients with Covid-19 Activ-3/Tico Ly-CoV555 Study Group New England Journal of Medicine 384 (10), 905-914, 2021 | 329 | 2021 |
| Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19 CT Bramante, JD Huling, CJ Tignanelli, JB Buse, DM Liebovitz, ... New England Journal of Medicine 387 (7), 599-610, 2022 | 189 | 2022 |
| Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis CT Bramante, NE Ingraham, TA Murray, S Marmor, S Hovertsen, ... The Lancet Healthy Longevity 2 (1), e34-e41, 2021 | 181 | 2021 |
| Observational study of metformin and risk of mortality in patients hospitalized with Covid-19 CT Bramante, NE Ingraham, TA Murray, S Marmor, S Hovertsen, ... MedRxiv, 2020 | 130 | 2020 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 124 | 2022 |
| Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial CT Bramante, JB Buse, DM Liebovitz, JM Nicklas, MA Puskarich, K Cohen, ... The Lancet Infectious Diseases 23 (10), 1119-1129, 2023 | 79 | 2023 |
| Comparative review of novel model‐assisted designs for phase I clinical trials H Zhou, TA Murray, H Pan, Y Yuan Statistics in Medicine 37 (14), 2208-2222, 2018 | 66 | 2018 |
| A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19 MA Puskarich, NW Cummins, NE Ingraham, DA Wacker, RA Reilkoff, ... EClinicalMedicine 37, 2021 | 62 | 2021 |
| Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: A randomised, double-blind, phase 3 trial TL Holland, AA Ginde, R Paredes, TA Murray, N Engen, G Grandits, ... The Lancet Respiratory Medicine 10 (10), 972-984, 2022 | 53 | 2022 |
| A Bayesian machine learning approach for optimizing dynamic treatment regimes TA Murray, Y Yuan, PF Thall Journal of the American Statistical Association 113 (523), 1255-1267, 2018 | 49 | 2018 |
| Efficacy of losartan in hospitalized patients with COVID-19–induced lung injury: a randomized clinical trial MA Puskarich, NE Ingraham, LH Merck, BE Driver, DA Wacker, LP Black, ... JAMA network open 5 (3), e222735-e222735, 2022 | 47 | 2022 |
| ACTIV-3/TICO LY-CoV555 Study Group. A neutralizing monoclonal antibody for hospitalized patients with Covid-19 JD Lundgren, B Grund, CE Barkauskas, TL Holland, RL Gottlieb, ... N Engl J Med 384 (10), 905-914, 2021 | 40 | 2021 |
| Should they stay or should they go? Who benefits from interfacility transfer to a higher-level trauma center following initial presentation at a lower-level trauma center T Adzemovic, T Murray, P Jenkins, J Ottosen, U Iyegha, K Raghavendran, ... Journal of Trauma and Acute Care Surgery 86 (6), 952-960, 2019 | 40 | 2019 |
| Estimating voter registration deadline effects with web search data A Street, TA Murray, J Blitzer, RS Patel Political Analysis 23 (2), 225-241, 2015 | 37 | 2015 |
| Semiparametric Bayesian commensurate survival model for post-market medical device surveillance with non-exchangeable historical data TA Murray, BP Hobbs, TC Lystig, BP Carlin Biometrics 70 (1), 185-191, 2014 | 33 | 2014 |
| Renin‐angiotensin system inhibitors in patients with COVID‐19: a meta‐analysis of randomized controlled trials led by the international society of hypertension SR Gnanenthiran, C Borghi, D Burger, B Caramelli, F Charchar, ... Journal of the American Heart Association 11 (17), e026143, 2022 | 28 | 2022 |
| Robust treatment comparison based on utilities of semi-competing risks in non-small-cell lung cancer TA Murray, PF Thall, Y Yuan, S McAvoy, DR Gomez Journal of the American Statistical Association 112 (517), 11-23, 2017 | 27 | 2017 |
| Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up CT Bramante, JB Buse, D Liebovitz, J Nicklas, MA Puskarich, K Cohen, ... medRxiv, 2022 | 26 | 2022 |
Christopher TignanelliUniversity of MinnesotaVerified email at umn.edu
